Examining Health-related Physical Fitness in Individuals With Diabetic Dyslipidemia.

NCT ID: NCT06829576

Last Updated: 2025-02-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

128 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-06-01

Study Completion Date

2022-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To compare health-related physical fitness parameters in Type 2DM patients with and without dyslipidemia.Cardiometabolic biomarkers glucose and lipid profile will be noted from medical records. Body composition, functional capacity will be assessed with a six-minute walk test, peripheral muscle strength with a dynamometer, and physical activity level with a pedometer.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetic Dyslipidemia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Having been diagnosed with Type 2 DM for at least 1 year,

* Having an HbA1c value between 6.5-11%,
* Being between the ages of 35-65,
* Knowing how to read and write Turkish,
* Having signed the informed consent form

Exclusion Criteria

* Lack of cooperation

* Patients with peripheral or central serious neurological disorders
* Patients with uncontrolled hypertension and uncontrolled arrhythmia
* Pregnant or lactating patients
* Patients with diabetic ulcers or neuropathy
* Chronic renal failure (eGFR\<30 ml/min)
* Chronic liver disease (ALT/AST\<3X Upper limit of normal)
* Patients with serious respiratory system disease
* Patients with cardiac pacemakers
* History of previous stroke or myocardial infarction
* Presence of lower and upper extremity orthopedic problems that may prevent the application of clinical tests
Minimum Eligible Age

35 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Biruni University

OTHER

Sponsor Role collaborator

Istanbul Galata University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Safak Yigit

PT, PhD(c)

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Buket Akinci, Assoc.Prof

Role: STUDY_DIRECTOR

Biruni University

Safak Yigit, PhD(c)

Role: PRINCIPAL_INVESTIGATOR

Istanbul Galata University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Istanbul Galata University

Istanbul, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GalataUni

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.